NFKB1 and head and neck cancer: In order to study the role of IKK/NF-κB to regulate EGFR inhibitor resistance in head and neck cancers, we cultured Cal27 cells in media that initially contained 0.5 μM of Gefitinb, which was increased to 5 μM over a 6-month span.